Xcell Therapeutics
Seoul · Founded 2015
About Xcell Therapeutics
Xcell Therapeutics develops and produces serum-free chemically defined media.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: IPO
- Last round: Series Unknown (Jan 2017)
- Ticker: kosdaq:373110
- Website: http://www.xcell.media/
- Phone: 82-2 863-1331
Industries & Categories
Biotechnology, Chemical, Health Care
Social Profiles
Canonical: https://fsome.com/organization/xcell-therapeutics-1429 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.